TEVA logo

TEVA Net income

annual net income:

-$1.96B-$1.34B(-218.54%)
December 31, 2024

Summary

  • As of today (August 16, 2025), TEVA annual net profit is -$1.96 billion, with the most recent change of -$1.34 billion (-218.54%) on December 31, 2024.
  • During the last 3 years, TEVA annual net income has fallen by -$2.42 billion (-529.61%).
  • TEVA annual net income is now -158.77% below its all-time high of $3.33 billion, reached on December 31, 2010.

Performance

TEVA Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

quarterly net income:

$287.87M+$67.87M(+30.85%)
June 30, 2025

Summary

  • As of today (August 16, 2025), TEVA quarterly net profit is $287.87 million, with the most recent change of +$67.87 million (+30.85%) on June 30, 2025.
  • Over the past year, TEVA quarterly net income has increased by +$1.16 billion (+132.94%).
  • TEVA quarterly net income is now -74.61% below its all-time high of $1.13 billion, reached on March 31, 2018.

Performance

TEVA quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

TTM net income:

-$157.13M+$1.16B(+88.09%)
June 30, 2025

Summary

  • As of today (August 16, 2025), TEVA TTM net profit is -$157.13 million, with the most recent change of +$1.16 billion (+88.09%) on June 30, 2025.
  • Over the past year, TEVA TTM net income has increased by +$593.87 million (+79.08%).
  • TEVA TTM net income is now -104.62% below its all-time high of $3.40 billion, reached on March 31, 2011.

Performance

TEVA TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

TEVA Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-218.5%+132.9%+79.1%
3 y3 years-529.6%+210.7%+85.2%
5 y5 years-95.9%+443.2%-2.7%

TEVA Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-529.6%+21.6%-38.2%+121.6%at high+93.7%
5 y5-year-529.6%+52.2%-38.2%+106.6%-120.4%+96.3%
alltimeall time-158.8%+88.1%-74.6%+102.5%-104.6%+99.0%

TEVA Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
$287.87M(+30.9%)
-$157.13M(-88.1%)
Mar 2025
-
$220.00M(-180.0%)
-$1.32B(-32.6%)
Dec 2024
-$1.96B(+218.5%)
-$275.00M(-29.5%)
-$1.96B(+60.9%)
Sep 2024
-
-$390.00M(-55.4%)
-$1.22B(+62.1%)
Jun 2024
-
-$874.00M(+108.6%)
-$751.00M(-4.1%)
Mar 2024
-
-$419.00M(-189.9%)
-$783.00M(+26.9%)
Dec 2023
-$615.00M(-75.4%)
$466.00M(+513.2%)
-$617.00M(-74.5%)
Sep 2023
-
$76.00M(-108.4%)
-$2.42B(-0.7%)
Jun 2023
-
-$906.00M(+258.1%)
-$2.43B(+36.2%)
Mar 2023
-
-$253.00M(-81.0%)
-$1.79B(-28.1%)
Dec 2022
-$2.50B(-648.0%)
-$1.33B(-2321.7%)
-$2.48B(+90.7%)
Sep 2022
-
$60.00M(-123.1%)
-$1.30B(+22.7%)
Jun 2022
-
-$260.00M(-72.7%)
-$1.06B(+82.8%)
Mar 2022
-
-$952.00M(+530.5%)
-$581.00M(-227.7%)
Dec 2021
$456.00M(-111.1%)
-$151.00M(-150.2%)
$455.00M(-40.8%)
Sep 2021
-
$301.00M(+36.2%)
$769.00M(-119.9%)
Jun 2021
-
$221.00M(+163.1%)
-$3.87B(-4.2%)
Mar 2021
-
$84.00M(-48.5%)
-$4.04B(-1.4%)
Dec 2020
-$4.10B(+310.0%)
$163.00M(-103.8%)
-$4.10B(-2.1%)
Sep 2020
-
-$4.34B(-8286.8%)
-$4.18B(+2635.3%)
Jun 2020
-
$53.00M(+112.0%)
-$153.00M(-82.6%)
Mar 2020
-
$25.00M(-67.1%)
-$877.00M(-12.2%)
Dec 2019
-$1.00B(-59.5%)
$76.00M(-124.8%)
-$999.00M(-76.9%)
Sep 2019
-
-$307.00M(-54.2%)
-$4.32B(+2.6%)
Jun 2019
-
-$671.00M(+591.8%)
-$4.21B(+13.6%)
Mar 2019
-
-$97.00M(-97.0%)
-$3.70B(+49.8%)
Dec 2018
-$2.47B(-85.0%)
-$3.24B(+1546.2%)
-$2.47B(-77.4%)
Sep 2018
-
-$197.00M(+18.7%)
-$10.96B(+7.9%)
Jun 2018
-
-$166.00M(-114.6%)
-$10.15B(-36.4%)
Mar 2018
-
$1.13B(-109.7%)
-$15.96B(-3.0%)
Dec 2017
-$16.45B(-5389.1%)
-$11.73B(-2023.0%)
-$16.45B(+188.9%)
Sep 2017
-
$610.00M(-110.2%)
-$5.69B(-3.4%)
Jun 2017
-
-$5.97B(-1031.4%)
-$5.89B(-1947.3%)
Mar 2017
-
$641.00M(-165.8%)
$319.00M(+2.6%)
Dec 2016
$311.00M(-80.5%)
-$974.00M(-337.6%)
$311.00M(-82.6%)
Sep 2016
-
$410.00M(+69.4%)
$1.78B(+19.7%)
Jun 2016
-
$242.00M(-61.8%)
$1.49B(-16.6%)
Mar 2016
-
$633.00M(+27.1%)
$1.79B(+11.8%)
Dec 2015
$1.60B(-47.5%)
$498.00M(+329.3%)
$1.60B(-10.9%)
Sep 2015
-
$116.00M(-78.5%)
$1.79B(-29.4%)
Jun 2015
-
$539.00M(+21.4%)
$2.54B(-7.5%)
Mar 2015
-
$444.00M(-36.0%)
$2.75B(-9.7%)
Dec 2014
$3.04B(+142.9%)
$694.00M(-19.6%)
$3.04B(+11.3%)
Sep 2014
-
$863.00M(+15.8%)
$2.73B(+5.2%)
Jun 2014
-
$745.00M(+0.7%)
$2.60B(+88.6%)
Mar 2014
-
$740.00M(+91.7%)
$1.38B(+7.4%)
Dec 2013
$1.25B(-34.2%)
$385.96M(-46.9%)
$1.28B(+9.0%)
Sep 2013
-
$727.29M(-253.0%)
$1.18B(+218.9%)
Jun 2013
-
-$475.32M(-173.7%)
$369.13M(-78.0%)
Mar 2013
-
$645.26M(+130.6%)
$1.68B(-9.3%)
Dec 2012
$1.90B(-30.9%)
$279.81M(-447.0%)
$1.85B(-9.9%)
Sep 2012
-
-$80.62M(-109.6%)
$2.06B(-32.6%)
Jun 2012
-
$835.98M(+2.2%)
$3.05B(+8.3%)
Mar 2012
-
$817.62M(+69.4%)
$2.81B(+1.3%)
Dec 2011
$2.75B(-17.4%)
$482.58M(-47.1%)
$2.78B(-9.5%)
Sep 2011
-
$911.90M(+51.3%)
$3.07B(-3.9%)
Jun 2011
-
$602.55M(-22.9%)
$3.19B(-6.0%)
Mar 2011
-
$781.92M(+1.2%)
$3.40B(+2.1%)
Dec 2010
$3.33B(+66.7%)
$772.69M(-25.5%)
$3.33B(+13.0%)
Sep 2010
-
$1.04B(+28.4%)
$2.95B(+15.5%)
Jun 2010
-
$807.66M(+13.4%)
$2.55B(+13.0%)
Mar 2010
-
$712.43M(+83.2%)
$2.26B(+12.6%)
Dec 2009
$2.00B(+226.9%)
$388.86M(-39.5%)
$2.01B(+116.8%)
Sep 2009
-
$643.05M(+25.0%)
$925.18M(+0.0%)
Jun 2009
-
$514.49M(+12.0%)
$925.14M(-1.5%)
Mar 2009
-
$459.51M(-166.4%)
$939.00M(+49.9%)
Dec 2008
$611.75M(-68.5%)
-$691.87M(-207.6%)
$626.55M(-67.2%)
Sep 2008
-
$643.01M(+21.7%)
$1.91B(+6.7%)
Jun 2008
-
$528.35M(+259.3%)
$1.79B(-0.3%)
Mar 2008
-
$147.06M(-75.0%)
$1.79B(-9.8%)
Dec 2007
$1.94B(+256.0%)
$589.17M(+12.5%)
$1.99B(+7.1%)
Sep 2007
-
$523.89M(-1.8%)
$1.86B(-4.1%)
Jun 2007
-
$533.77M(+55.9%)
$1.94B(+2.5%)
Mar 2007
-
$342.45M(-25.1%)
$1.89B(+251.6%)
Dec 2006
$545.27M
$457.08M(-24.2%)
$537.24M(+43.1%)
Sep 2006
-
$603.14M(+24.0%)
$375.54M(+1000.1%)
Jun 2006
-
$486.51M(-148.2%)
$34.14M(-116.3%)
DateAnnualQuarterlyTTM
Mar 2006
-
-$1.01B(-441.7%)
-$209.78M(-119.7%)
Dec 2005
$1.08B(+220.9%)
$295.39M(+12.9%)
$1.06B(+1.0%)
Sep 2005
-
$261.73M(+7.9%)
$1.05B(+0.9%)
Jun 2005
-
$242.59M(-8.4%)
$1.04B(+1.5%)
Mar 2005
-
$264.83M(-7.1%)
$1.03B(+204.7%)
Dec 2004
$335.46M(-51.3%)
$285.11M(+13.2%)
$337.59M(+39.3%)
Sep 2004
-
$251.97M(+11.1%)
$242.36M(+58.1%)
Jun 2004
-
$226.74M(-153.2%)
$153.30M(+5.4%)
Mar 2004
-
-$426.24M(-324.5%)
$145.47M(-79.5%)
Dec 2003
$688.54M(+66.8%)
$189.88M(+16.6%)
$707.90M(+8.0%)
Sep 2003
-
$162.91M(-25.6%)
$655.50M(+11.6%)
Jun 2003
-
$218.91M(+60.7%)
$587.42M(+29.4%)
Mar 2003
-
$136.19M(-0.9%)
$453.88M(+12.4%)
Dec 2002
$412.67M(+48.7%)
$137.49M(+45.0%)
$403.79M(+16.7%)
Sep 2002
-
$94.83M(+11.1%)
$345.91M(+5.1%)
Jun 2002
-
$85.37M(-0.8%)
$328.97M(+7.0%)
Mar 2002
-
$86.10M(+8.1%)
$307.59M(+11.4%)
Dec 2001
$277.49M(+86.0%)
$79.61M(+2.2%)
$276.08M(+40.5%)
Sep 2001
-
$77.89M(+21.7%)
$196.47M(+65.7%)
Jun 2001
-
$63.99M(+17.2%)
$118.58M(+117.2%)
Mar 2001
-
$54.59M(>+9900.0%)
$54.59M(>+9900.0%)
Dec 2000
$149.17M(-69.3%)
$0.00(-100.0%)
$0.00(-100.0%)
Dec 1999
$486.14M(+86.0%)
-
-
Dec 1998
$261.39M(+157.2%)
-
-
Sep 1998
-
$24.60M(+48.2%)
$66.21M(-14.5%)
Jun 1998
-
$16.60M(-32.9%)
$77.42M(-18.4%)
Mar 1998
-
$24.72M(+8139.8%)
$94.82M(-6.7%)
Dec 1997
$101.62M(+39.0%)
$300.00K(-99.2%)
$101.60M(-22.7%)
Sep 1997
-
$35.80M(+5.3%)
$131.50M(+9.9%)
Jun 1997
-
$34.00M(+7.9%)
$119.60M(+44.8%)
Mar 1997
-
$31.50M(+4.3%)
$82.60M(+12.5%)
Dec 1996
$73.11M(-11.3%)
$30.20M(+26.4%)
$73.40M(+37.2%)
Sep 1996
-
$23.90M(-896.7%)
$53.50M(+4.5%)
Jun 1996
-
-$3.00M(-113.5%)
$51.20M(-30.5%)
Mar 1996
-
$22.30M(+116.5%)
$73.70M(+4.8%)
Dec 1995
$82.43M(+14.8%)
$10.30M(-52.3%)
$70.30M(-6.1%)
Sep 1995
-
$21.60M(+10.8%)
$74.90M(+5.8%)
Jun 1995
-
$19.50M(+3.2%)
$70.80M(+1.9%)
Mar 1995
-
$18.90M(+26.8%)
$69.50M(+2.7%)
Dec 1994
$71.80M(+17.9%)
$14.90M(-14.9%)
$67.70M(-1.9%)
Sep 1994
-
$17.50M(-3.8%)
$69.00M(+5.5%)
Jun 1994
-
$18.20M(+6.4%)
$65.40M(+7.0%)
Mar 1994
-
$17.10M(+5.6%)
$61.10M(+6.3%)
Dec 1993
$60.89M(+69.6%)
$16.20M(+16.5%)
$57.50M(+10.8%)
Sep 1993
-
$13.90M(0.0%)
$51.90M(+16.1%)
Jun 1993
-
$13.90M(+3.0%)
$44.70M(+18.3%)
Mar 1993
-
$13.50M(+27.4%)
$37.80M(+18.1%)
Dec 1992
$35.90M(+51.5%)
$10.60M(+58.2%)
$32.00M(+12.7%)
Sep 1992
-
$6.70M(-4.3%)
$28.40M(+7.6%)
Jun 1992
-
$7.00M(-9.1%)
$26.40M(+0.8%)
Mar 1992
-
$7.70M(+10.0%)
$26.20M(+10.5%)
Dec 1991
$23.70M(+13.9%)
$7.00M(+48.9%)
$23.70M(-9.5%)
Sep 1991
-
$4.70M(-30.9%)
$26.20M(+4.8%)
Jun 1991
-
$6.80M(+30.8%)
$25.00M(+14.2%)
Mar 1991
-
$5.20M(-45.3%)
$21.90M(+3.3%)
Dec 1990
$20.80M(+23.1%)
$9.50M(+171.4%)
$21.20M(+26.9%)
Sep 1990
-
$3.50M(-5.4%)
$16.70M(0.0%)
Jun 1990
-
$3.70M(-17.8%)
$16.70M(+1.2%)
Mar 1990
-
$4.50M(-10.0%)
$16.50M(-2.4%)
Dec 1989
$16.90M(+40.8%)
$5.00M(+42.9%)
$16.90M(+15.8%)
Sep 1989
-
$3.50M(0.0%)
$14.60M(+10.6%)
Jun 1989
-
$3.50M(-28.6%)
$13.20M(-0.8%)
Mar 1989
-
$4.90M(+81.5%)
$13.30M(+10.8%)
Dec 1988
$12.00M(-18.9%)
$2.70M(+28.6%)
$12.00M(+29.0%)
Sep 1988
-
$2.10M(-41.7%)
$9.30M(-7.0%)
Jun 1988
-
$3.60M(0.0%)
$10.00M(+8.7%)
Mar 1988
-
$3.60M(+28.6%)
$9.20M(-29.2%)
Sep 1987
-
$2.80M(0.0%)
$13.00M(-6.5%)
Jun 1987
-
$2.80M(-24.3%)
$13.90M(-6.1%)
Mar 1987
$14.80M(+94.7%)
$3.70M(0.0%)
$14.80M(+13.8%)
Dec 1986
-
$3.70M(0.0%)
$13.00M(+16.1%)
Sep 1986
-
$3.70M(0.0%)
$11.20M(+19.1%)
Jun 1986
-
$3.70M(+94.7%)
$9.40M(+23.7%)
Mar 1986
$7.60M
$1.90M(0.0%)
$7.60M(+33.3%)
Dec 1985
-
$1.90M(0.0%)
$5.70M(+50.0%)
Sep 1985
-
$1.90M(0.0%)
$3.80M(+100.0%)
Jun 1985
-
$1.90M
$1.90M

FAQ

  • What is Teva Pharmaceutical Industries Limited annual net profit?
  • What is the all time high annual net income for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual net income year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly net profit?
  • What is the all time high quarterly net income for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly net income year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM net profit?
  • What is the all time high TTM net income for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM net income year-on-year change?

What is Teva Pharmaceutical Industries Limited annual net profit?

The current annual net income of TEVA is -$1.96B

What is the all time high annual net income for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual net profit is $3.33B

What is Teva Pharmaceutical Industries Limited annual net income year-on-year change?

Over the past year, TEVA annual net profit has changed by -$1.34B (-218.54%)

What is Teva Pharmaceutical Industries Limited quarterly net profit?

The current quarterly net income of TEVA is $287.87M

What is the all time high quarterly net income for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly net profit is $1.13B

What is Teva Pharmaceutical Industries Limited quarterly net income year-on-year change?

Over the past year, TEVA quarterly net profit has changed by +$1.16B (+132.94%)

What is Teva Pharmaceutical Industries Limited TTM net profit?

The current TTM net income of TEVA is -$157.13M

What is the all time high TTM net income for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM net profit is $3.40B

What is Teva Pharmaceutical Industries Limited TTM net income year-on-year change?

Over the past year, TEVA TTM net profit has changed by +$593.87M (+79.08%)
On this page